vs
Side-by-side financial comparison of Capri Holdings Ltd (CPRI) and Enovis CORP (ENOV). Click either name above to swap in a different company.
Capri Holdings Ltd is the larger business by last-quarter revenue ($1.0B vs $548.9M, roughly 1.9× Enovis CORP). Capri Holdings Ltd runs the higher net margin — 11.3% vs -104.1%, a 115.4% gap on every dollar of revenue. On growth, Enovis CORP posted the faster year-over-year revenue change (-2.2% vs -18.7%). Capri Holdings Ltd produced more free cash flow last quarter ($183.0M vs $29.1M). Over the past eight quarters, Enovis CORP's revenue compounded faster (9.8% CAGR vs -15.2%).
Capri Holdings Limited is a multinational fashion holding company, incorporated in the British Virgin Islands, with executive offices in London and operational offices in New York. It was founded in 1981 by American designer Michael Kors. The company sells clothes, shoes, watches, handbags, and other accessories. In 2015, the company had more than 550 stores and over 1,500 in-store boutiques in various countries.
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.
CPRI vs ENOV — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $548.9M |
| Net Profit | $116.0M | $-571.1M |
| Gross Margin | 60.8% | 59.9% |
| Operating Margin | 4.5% | -101.7% |
| Net Margin | 11.3% | -104.1% |
| Revenue YoY | -18.7% | -2.2% |
| Net Profit YoY | 121.2% | 18.8% |
| EPS (diluted) | $0.96 | $-9.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $548.9M | ||
| Q3 25 | $856.0M | $564.5M | ||
| Q2 25 | $797.0M | $558.8M | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.1B | $561.0M | ||
| Q3 24 | $878.0M | $505.2M | ||
| Q2 24 | $848.0M | $525.2M | ||
| Q1 24 | — | $516.3M |
| Q4 25 | $116.0M | $-571.1M | ||
| Q3 25 | $-28.0M | $-36.7M | ||
| Q2 25 | $53.0M | $-56.0M | ||
| Q1 25 | $-645.0M | — | ||
| Q4 24 | $-547.0M | $-703.2M | ||
| Q3 24 | $24.0M | $-31.5M | ||
| Q2 24 | $-14.0M | $-18.6M | ||
| Q1 24 | — | $-72.0M |
| Q4 25 | 60.8% | 59.9% | ||
| Q3 25 | 61.0% | 59.3% | ||
| Q2 25 | 63.0% | 59.5% | ||
| Q1 25 | 64.9% | — | ||
| Q4 24 | 63.1% | 54.8% | ||
| Q3 24 | 62.3% | 56.7% | ||
| Q2 24 | 63.1% | 55.0% | ||
| Q1 24 | — | 57.7% |
| Q4 25 | 4.5% | -101.7% | ||
| Q3 25 | -1.4% | -3.0% | ||
| Q2 25 | 2.0% | -8.4% | ||
| Q1 25 | -47.5% | — | ||
| Q4 24 | 2.4% | -118.5% | ||
| Q3 24 | -0.7% | -6.3% | ||
| Q2 24 | 1.3% | -8.4% | ||
| Q1 24 | — | -6.8% |
| Q4 25 | 11.3% | -104.1% | ||
| Q3 25 | -3.3% | -6.5% | ||
| Q2 25 | 6.6% | -10.0% | ||
| Q1 25 | -39.1% | — | ||
| Q4 24 | -51.2% | -125.4% | ||
| Q3 24 | 2.7% | -6.2% | ||
| Q2 24 | -1.7% | -3.5% | ||
| Q1 24 | — | -13.9% |
| Q4 25 | $0.96 | $-9.99 | ||
| Q3 25 | $-0.22 | $-0.64 | ||
| Q2 25 | $0.44 | $-0.98 | ||
| Q1 25 | $-5.47 | — | ||
| Q4 24 | $-4.61 | $-12.69 | ||
| Q3 24 | $0.20 | $-0.58 | ||
| Q2 24 | $-0.12 | $-0.34 | ||
| Q1 24 | — | $-1.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $154.0M | $33.6M |
| Total DebtLower is stronger | $234.0M | $1.4B |
| Stockholders' EquityBook value | $105.0M | $2.0B |
| Total Assets | $3.3B | $4.4B |
| Debt / EquityLower = less leverage | 2.23× | 0.67× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $154.0M | $33.6M | ||
| Q3 25 | $120.0M | $44.1M | ||
| Q2 25 | $129.0M | $38.5M | ||
| Q1 25 | $107.0M | — | ||
| Q4 24 | $356.0M | $48.2M | ||
| Q3 24 | $182.0M | $35.4M | ||
| Q2 24 | $213.0M | $35.0M | ||
| Q1 24 | — | $66.3M |
| Q4 25 | $234.0M | $1.4B | ||
| Q3 25 | $1.8B | $1.4B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.7B | $1.3B | ||
| Q2 24 | $1.7B | $1.3B | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $105.0M | $2.0B | ||
| Q3 25 | $-74.0M | $2.6B | ||
| Q2 25 | $-17.0M | $2.6B | ||
| Q1 25 | $368.0M | — | ||
| Q4 24 | $1.1B | $2.6B | ||
| Q3 24 | $1.5B | $3.3B | ||
| Q2 24 | $1.6B | $3.3B | ||
| Q1 24 | — | $3.3B |
| Q4 25 | $3.3B | $4.4B | ||
| Q3 25 | $5.6B | $5.0B | ||
| Q2 25 | $5.5B | $4.9B | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.9B | $4.7B | ||
| Q3 24 | $6.8B | $5.6B | ||
| Q2 24 | $6.6B | $5.4B | ||
| Q1 24 | — | $5.5B |
| Q4 25 | 2.23× | 0.67× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | 4.05× | — | ||
| Q4 24 | 1.38× | 0.52× | ||
| Q3 24 | 1.15× | 0.40× | ||
| Q2 24 | 1.08× | 0.41× | ||
| Q1 24 | — | 0.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $202.0M | $82.6M |
| Free Cash FlowOCF − Capex | $183.0M | $29.1M |
| FCF MarginFCF / Revenue | 17.9% | 5.3% |
| Capex IntensityCapex / Revenue | 1.9% | 9.7% |
| Cash ConversionOCF / Net Profit | 1.74× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-134.0M | $22.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $202.0M | $82.6M | ||
| Q3 25 | $-52.0M | $47.8M | ||
| Q2 25 | $-8.0M | $-1.6M | ||
| Q1 25 | $-161.0M | — | ||
| Q4 24 | $309.0M | $88.3M | ||
| Q3 24 | $50.0M | $53.6M | ||
| Q2 24 | $83.0M | $7.8M | ||
| Q1 24 | — | $-36.2M |
| Q4 25 | $183.0M | $29.1M | ||
| Q3 25 | $-65.0M | $3.4M | ||
| Q2 25 | $-21.0M | $-44.9M | ||
| Q1 25 | $-231.0M | — | ||
| Q4 24 | $287.0M | $35.1M | ||
| Q3 24 | $30.0M | $2.4M | ||
| Q2 24 | $67.0M | $-31.6M | ||
| Q1 24 | — | $-73.1M |
| Q4 25 | 17.9% | 5.3% | ||
| Q3 25 | -7.6% | 0.6% | ||
| Q2 25 | -2.6% | -8.0% | ||
| Q1 25 | -14.0% | — | ||
| Q4 24 | 26.9% | 6.3% | ||
| Q3 24 | 3.4% | 0.5% | ||
| Q2 24 | 7.9% | -6.0% | ||
| Q1 24 | — | -14.2% |
| Q4 25 | 1.9% | 9.7% | ||
| Q3 25 | 1.5% | 7.9% | ||
| Q2 25 | 1.6% | 7.7% | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 2.1% | 9.5% | ||
| Q3 24 | 2.3% | 10.1% | ||
| Q2 24 | 1.9% | 7.5% | ||
| Q1 24 | — | 7.2% |
| Q4 25 | 1.74× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.15× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.08× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CPRI
| Michael Kors Segment | $593.0M | 58% |
| Other | $379.0M | 37% |
| Jimmy Choo Segment | $53.0M | 5% |
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |
